These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 35517783)
1. BI 1015550 is a PDE4B Inhibitor and a Clinical Drug Candidate for the Oral Treatment of Idiopathic Pulmonary Fibrosis. Herrmann FE; Hesslinger C; Wollin L; Nickolaus P Front Pharmacol; 2022; 13():838449. PubMed ID: 35517783 [TBL] [Abstract][Full Text] [Related]
2. BI 1015550: an investigational phosphodiesterase 4B (PDE4B) inhibitor for lung function decline in idiopathic pulmonary fibrosis (IPF). Sgalla G; Simonetti J; Cortese S; Richeldi L Expert Opin Investig Drugs; 2023 Jan; 32(1):17-23. PubMed ID: 36693635 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of phosphodiesterase 4 (PDE4) reduces dermal fibrosis by interfering with the release of interleukin-6 from M2 macrophages. Maier C; Ramming A; Bergmann C; Weinkam R; Kittan N; Schett G; Distler JHW; Beyer C Ann Rheum Dis; 2017 Jun; 76(6):1133-1141. PubMed ID: 28209630 [TBL] [Abstract][Full Text] [Related]
4. Antifibrotic and anti-inflammatory activity of the tyrosine kinase inhibitor nintedanib in experimental models of lung fibrosis. Wollin L; Maillet I; Quesniaux V; Holweg A; Ryffel B J Pharmacol Exp Ther; 2014 May; 349(2):209-20. PubMed ID: 24556663 [TBL] [Abstract][Full Text] [Related]
5. The unrecognized effects of phosphodiesterase 4 on epithelial cells in pulmonary inflammation. Konrad FM; Bury A; Schick MA; Ngamsri KC; Reutershan J PLoS One; 2015; 10(4):e0121725. PubMed ID: 25909327 [TBL] [Abstract][Full Text] [Related]
6. Phosphodiesterase 4 inhibition in the treatment of psoriasis, psoriatic arthritis and other chronic inflammatory diseases. Wittmann M; Helliwell PS Dermatol Ther (Heidelb); 2013 Jun; 3(1):1-15. PubMed ID: 23888251 [TBL] [Abstract][Full Text] [Related]
7. A multi-target antisense approach against PDE4 and PDE7 reduces smoke-induced lung inflammation in mice. Fortin M; D'Anjou H; Higgins ME; Gougeon J; Aubé P; Moktefi K; Mouissi S; Séguin S; Séguin R; Renzi PM; Paquet L; Ferrari N Respir Res; 2009 May; 10(1):39. PubMed ID: 19457265 [TBL] [Abstract][Full Text] [Related]
8. Phosphodiesterase 4 in inflammatory diseases: Effects of apremilast in psoriatic blood and in dermal myofibroblasts through the PDE4/CD271 complex. Schafer PH; Truzzi F; Parton A; Wu L; Kosek J; Zhang LH; Horan G; Saltari A; Quadri M; Lotti R; Marconi A; Pincelli C Cell Signal; 2016 Jul; 28(7):753-63. PubMed ID: 26806620 [TBL] [Abstract][Full Text] [Related]
9. The preclinical pharmacology of roflumilast--a selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease. Hatzelmann A; Morcillo EJ; Lungarella G; Adnot S; Sanjar S; Beume R; Schudt C; Tenor H Pulm Pharmacol Ther; 2010 Aug; 23(4):235-56. PubMed ID: 20381629 [TBL] [Abstract][Full Text] [Related]
10. GSK256066, an exceptionally high-affinity and selective inhibitor of phosphodiesterase 4 suitable for administration by inhalation: in vitro, kinetic, and in vivo characterization. Tralau-Stewart CJ; Williamson RA; Nials AT; Gascoigne M; Dawson J; Hart GJ; Angell AD; Solanke YE; Lucas FS; Wiseman J; Ward P; Ranshaw LE; Knowles RG J Pharmacol Exp Ther; 2011 Apr; 337(1):145-54. PubMed ID: 21205923 [TBL] [Abstract][Full Text] [Related]
11. Specific role of phosphodiesterase 4B in lipopolysaccharide-induced signaling in mouse macrophages. Jin SL; Lan L; Zoudilova M; Conti M J Immunol; 2005 Aug; 175(3):1523-31. PubMed ID: 16034090 [TBL] [Abstract][Full Text] [Related]
12. Sappanone A: A natural PDE4 inhibitor with dual anti-inflammatory and antioxidant activities from the heartwood of Caesalpinia sappan L. Wang YZ; Wang YL; Che HJ; Jia YH; Wang HF; Zuo LF; Yang K; Li TT; Wang JX J Ethnopharmacol; 2023 Mar; 304():116020. PubMed ID: 36529254 [TBL] [Abstract][Full Text] [Related]
14. Effects of ciclamilast, a new PDE 4 PDE4 inhibitor, on airway hyperresponsiveness, PDE4D expression and airway inflammation in a murine model of asthma. Deng YM; Xie QM; Tang HF; Sun JG; Deng JF; Chen JQ; Yang SY Eur J Pharmacol; 2006 Oct; 547(1-3):125-35. PubMed ID: 16956605 [TBL] [Abstract][Full Text] [Related]